DISCOUNT ZERTIFIKAT - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 15:40:15 2024-05-31 EDT | ||
| 36.25 EUR | +1.31% |
|
| Current month | -7.27% | ||
| 1 month | -7.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 36.25 | +1.31% |
| 24-05-30 | 35.78 | -0.69% |
| 24-05-29 | 36.03 | +0.67% |
| 24-05-28 | 35.79 | -2.45% |
| 24-05-27 | 36.69 | +0.85% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 03:40 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PE9PM0 |
| ISIN | DE000PE9PM03 |
| Date issued | 2023-02-22 |
| Maturity | 2024-12-20 (202 Days) |
| Parity | 1 : 1 |
| Emission price | 40.82 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 42.88 € |
|---|---|
| Lowest since issue | 35.53 € |
| Spread | 0.07 € |
| Spread % | 0.19% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
